HB0152 would create a new Wyoming law governing blood donations and transfusions by requiring blood collection entities to ask donors whether they have ever received a COVID-19 vaccine or an mRNA vaccine. If the donor has received either type of vaccine, the donated blood must be conspicuously marked on the blood packaging and related paperwork.
The bill also gives a transfusion recipient, in a nonemergency situation as determined by the treating health care provider, the right to request blood from a donor who has not received a COVID-19 or mRNA vaccine, if such blood is available at the facility. The Department of Health would be required to adopt rules to implement the act, and the bill would take effect July 1, 2025.
Impact
HB0152 would add a new article to Wyoming law regulating blood donation disclosures and transfusion preferences. It would impose new obligations on blood collection organizations to obtain vaccination-status disclosures, label certain donated blood, and maintain related documentation, while also creating a patient-facing right to request specific blood in nonemergency transfusions when available. The bill would likely affect blood banks, hospitals, transfusion services, and the Department of Health through required rulemaking and compliance procedures.
Sentiment
Based on the bill text and sponsorship, the measure appears to be driven by concern among supporters about vaccine status in donated blood and patient choice in transfusions. The bill has multiple sponsors in both chambers, suggesting organized support. No committee transcript or vote record is available here, so there is no direct evidence of opposition or debate in the provided materials.
Contention
The main point of contention is likely the requirement to disclose and label blood based on prior COVID-19 or mRNA vaccination, which could raise operational, medical, and scientific concerns for blood collection and hospital providers. Another likely issue is the new right for transfusion recipients to request vaccine-status-specific blood only in nonemergency situations and only if available, which may be seen by supporters as informed choice but by opponents as potentially burdensome or medically unnecessary. The bill text does not include any recorded committee objections, so specific dissenting positions are not documented in the provided materials.